Retinopathy of Prematurity and the Oxygen Conundrum: Lessons Learned from Recent Randomized Trials

Clinics in Perinatology

Volumn 40, Issue 2, 2013, Pages 229-240

  Fleck, Brian W ^a   Stenson, Ben J ^b  

^a Princess Alexandra Eye Pavilion ^*  (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Neonatal Oxygenation Prospective Meta analysis (NeoPROM) collaboration; Oxygen supplementation; Preterm infants; Retinopathy of prematurity

Indexed keywords

OXYGEN; SOMATOMEDIN C; VASCULOTROPIN;

ANGIOGENESIS; ARTERIAL GAS; AUSTRALIA; HEALTH CARE PLANNING; HUMAN; HYPEROXIA; HYPOXIA; INFANT MORTALITY; MONITORING; MORBIDITY; OXIMETRY; OXYGEN SATURATION; OXYGEN THERAPY; PATHOGENESIS; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA BLOOD VESSEL; RETINA DEVELOPMENT; RETROLENTAL FIBROPLASIA; REVIEW; SUPPLEMENTATION; TREATMENT OUTCOME; UNITED KINGDOM;

HISTORY, 20TH CENTURY; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; OXYGEN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETINOPATHY OF PREMATURITY;

EID: 84878170868     PISSN: 00955108     EISSN: 15579840     Source Type: Journal    
DOI: 10.1016/j.clp.2013.02.010     Document Type: Review

References (37)

1. Terry T.L. Fibroblastic overgrowth of persistent tunica vasculosa lentis in infants born prematurely: II. Report of cases-clinical aspects. Trans Am Ophthalmol Soc 1942, 40:262-284.
2. Campbell K. Intensive oxygen therapy as a possible cause of retrolental fibroplasia; a clinical approach. Med J Aust 1951, 2(2):48-50.
3. Patz A., Hoeck L.E., De La Cruz E. Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations. Am J Ophthalmol 1952, 35(9):1248-1253.
4. Ashton N. Animal experiments in retrolental fibroplasia. Trans Am Acad Ophthalmol Otolaryngol 1954, 58(1):51-53. [discussion: 53-4].
5. Ashton N. Retrolental fibroplasia. Am J Ophthalmol 1955, 39(4 Pt 2):153-159.
6. Askie L.M., Henderson-Smart D.J., Ko H. Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants. Cochrane Database Syst Rev 2009, (1). [meta-analysis review], CD001077.
7. Kinsey V.E. Retrolental fibroplasia; cooperative study of retrolental fibroplasia and the use of oxygen. AMA Arch Ophthalmol 1956, 56(4):481-543.
8. Guy L.P., Lanman J.T., Dancis J. The possibility of total elimination of retrolental fibroplasia by oxygen restriction. Pediatrics 1956, 17(2):247-249.
9. Cross K.W. Cost of preventing retrolental fibroplasia?. Lancet 1973, 2(7835):954-956.
10. 2 levels and retrolental fibroplasia: a report of the cooperative study. Pediatrics 1977, 60(5):655-668.
11. Yu V.Y., Hookham D.M., Nave J.R. Retrolental fibroplasia-controlled study of 4 years' experience in a neonatal intensive care unit. Arch Dis Child 1982, 57(4):247-252.
12. Bancalari E., Flynn J., Goldberg R.N., et al. Influence of transcutaneous oxygen monitoring on the incidence of retinopathy of prematurity. Pediatrics 1987, 79(5):663-669.
13. Flynn J.T., Bancalari E., Snyder E.S., et al. A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. Trans Am Ophthalmol Soc 1991, 89:77-92. [discussion: 92-5].
14. Myers T.R., American Association for Respir Care AARC Clinical Practice Guideline: selection of an oxygen delivery device for neonatal and pediatric patients-2002 revision & update. Respir Care 2002, 47(6):707-716.
15. Quine D., Stenson B.J. Does the monitoring method influence stability of oxygenation in preterm infants? A randomised crossover study of saturation versus transcutaneous monitoring. Arch Dis Child Fetal Neonatal Ed 2008, 93(5):F347-F350.
16. Cunningham S., Fleck B.W., Elton R.A., et al. Transcutaneous oxygen levels in retinopathy of prematurity. Lancet 1995, 346(8988):1464-1465.
17. Tin W., Milligan D.W., Pennefather P., et al. Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Arch Dis Child Fetal Neonatal Ed 2001, 84(2):F106-F110.
18. Anderson C.G., Benitz W.E., Madan A. Retinopathy of prematurity and pulse oximetry: a national survey of recent practices. J Perinatol 2004, 24(3):164-168.
19. Chan-Ling T., Gock B., Stone J. The effect of oxygen on vasoformative cell division. Evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis. Invest Ophthalmol Vis Sci 1995, 36(7):1201-1214.
20. Fleck B.W., McIntosh N. Pathogenesis of retinopathy of prematurity and possible preventive strategies. Early Hum Dev 2008, 84(2):83-88. [review].
21. Hellstrom A., Engstrom E., Hard A.L., et al. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics 2003, 112(5):1016-1020.
22. Hellstrom A., Perruzzi C., Ju M., et al. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A 2001, 98(10):5804-5808.
23. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics 2000, 105(2):295-310.
24. Chow L.C., Wright K.W., Sola A., Group COAS Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants?. Pediatrics 2003, 111(2):339-345.
25. Askie L.M., Henderson-Smart D.J., Irwig L., et al. Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med 2003, 349(10):959-967.
26. Askie L.M., Brocklehurst P., Darlow B.A., et al. NeOProM: neonatal oxygenation prospective meta-analysis collaboration study protocol. BMC Pediatr 2011, 11:6.
27. Newburger J.W., Silbert A.R., Buckley L.P., et al. Cognitive function and age at repair of transposition of the great arteries in children. N Engl J Med 1984, 310(23):1495-1499.
28. Skinner J.R., Hunter S., Poets C.F., et al. Haemodynamic effects of altering arterial oxygen saturation in preterm infants with respiratory failure. Arch Dis Child Fetal Neonatal Ed 1999, 80(2):F81-F87.
29. Subhedar N.V., Shaw N.J. Changes in pulmonary arterial pressure in preterm infants with chronic lung disease. Arch Dis Child Fetal Neonatal Ed 2000, 82(3):F243-F247.
30. Johnston E.D., Boyle B., Juszczak E., et al. Oxygen targeting in preterm infants using the Masimo SET Radical pulse oximeter. Arch Dis Child Fetal Neonatal Ed 2011, 96(6):F429-F433.
31. SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network, Carlo W.A., Finer N.N., Walsh M.C., et al. Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med 2010, 362(21):1959-1969.
32. Stenson B., Brocklehurst P., Tarnow-Mordi W., et al. Increased 36-week survival with high oxygen saturation target in extremely preterm infants. N Engl J Med 2011, 364(17):1680-1682.
33. Vaucher Y.E., Peralta-Carcelen M., Finer N.N., et al. Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial. N Engl J Med 2012, 367(26):2495-2504.
34. VanderVeen D.K., Coats D.K., Dobson V., et al. Prevalence and course of strabismus in the first year of life for infants with prethreshold retinopathy of prematurity: findings from the Early Treatment for Retinopathy of Prematurity study. Arch Ophthalmol 2006, 124(6):766-773.
35. Quinn G.E., Dobson V., Davitt B.V., et al. Progression of myopia and high myopia in the early treatment for retinopathy of prematurity study: findings to 3 years of age. Ophthalmology 2008, 115(6):1058-1064.e1.
36. Early Treatment For Retinopathy Of Prematurity Cooperative Group Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 2003, 121(12):1684-1694.
37. 2) values in infants <29 weeks of gestation at currently targeted saturations. Arch Dis Child Fetal Neonatal Ed 2009, 94(1):F51-F53.